scholarly journals Uncommon Occurrence of an Air Embolism during the Preanhepatic Phase of an Orthotopic Liver Transplant

2021 ◽  
Vol 2021 ◽  
pp. 1-3
Author(s):  
Klint J. Smart ◽  
Saman Yaghoubian

Vascular air embolism (VAE) during liver transplantation usually occurs during the dissection phase of the procedure or during liver reperfusion. If this phenomenon occurs, it can cause significant cardiovascular, pulmonary, and neurological complications. Prompt identification of VAE is essential, and the surgeon should be immediately notified. The mainstay treatment is identification and rectification of the source of the air embolus, hemodynamic support, and prevention of further air entrainment. This case report describes the occurrence of a pulmonary air embolism during the preanhepatic phase of an orthotopic liver transplant.

2005 ◽  
Vol 8 (4) ◽  
pp. 449-451
Author(s):  
Marcelo A. F. Ribeiro Jr ◽  
Christian Evangelista Garcia ◽  
Telma Eugênio dos Santos ◽  
Adavio de Oliveira e Silva ◽  
Regina Leitão ◽  
...  

Introduction: Epithelioid hemangioendothelioma of liver is a rare, low-grade neoplasm of vascular origin that has an unpredictable malignant potential. It preferentially arises in soft tissues and bones, and seldom in the liver. Biologically, it trends to be multi-focal and often unresectable. Objective: The outcome of a patient submitted to a living-related liver transplant to treat epithelioid hemangioendothelioma of the liver. Case report: The reported case involves a 39-year old female patient with an immense epithelioid hemangioendothelioma of the liver, involving segments III, IV, V, VII, and VIIl. The prognostic to any kind of treatment was considered unfavorable, and the decision of submitting her to a liver transplant was made. It was suggested a living-related liver transplant. The donor was the patient’s 36-year old brother, who donated his right liver lobe (segments V, VI, VII, VIII). The recipient´s original liver was large, presenting very solid consistence and no node evidence. The transplant itself was performed using the conventional living-related liver transplantation technique. The recovery was good, and she was discharged from hospital on the 15th postoperative day using micophenolate mofetil, tacrolimus, and corticoid. Conclusion: Liver transplantation for epithelioid hemangioendothelioma of the liver can be performed with acceptable survival rate. The living related liver transplant opens a great perspective to that group of patients presenting liver tumors and who are unfeasible to wait for an organ on a waiting list.


2018 ◽  
Vol 184 (1) ◽  
pp. 177-180 ◽  
Author(s):  
Pakpoom Phoompoung ◽  
Methee Chayakulkeeree ◽  
Popchai Ngamskulrungroj ◽  
Ananya Pongpaibul

2014 ◽  
Vol 16 (suppl 2) ◽  
pp. ii52-ii52
Author(s):  
R. Fornaro ◽  
A. Agnoletti ◽  
F. M. C. Specchia ◽  
D. Garbossa ◽  
M. Lanotte ◽  
...  

2017 ◽  
Vol 3 (3) ◽  
pp. e134 ◽  
Author(s):  
Adam Badenoch ◽  
Coimbatore Srinivas ◽  
David Al-Adra ◽  
Markus Selzner ◽  
Marcin Wąsowicz

2017 ◽  
Vol 27 (3) ◽  
pp. 246-250 ◽  
Author(s):  
Dipti Banerjee ◽  
Lindsey E. Roeker ◽  
Martha Grogan ◽  
Paul Swiecicki ◽  
John Poterucha ◽  
...  

Background: Familial transthyretin amyloidosis is a disease caused by misfolded transthyretin aggregates that can impair multiple organ systems. Liver transplantation is the first-line treatment for familial transthyretin amyloidosis. Research Question: Our objective is to study outcomes and survival among patients with familial transthyretin amyloidosis after transplantation. Design: All patients undergoing orthotopic liver transplant for familial transthyretin amyloidosis at Mayo Clinic between 1997 and 2012 were reviewed. Baseline clinical characteristics, organs transplanted, and posttransplant clinical course were assessed. Results: Of the 40 patients, 7 patients had the V30M mutation and 33 had other mutations. Nineteen patients received liver only, 19 liver and heart, and 2 combined liver, heart, and kidney transplants. The 5-year overall survival was 85% for those receiving multiple organ transplant and 52% for those receiving liver transplant only ( P = .057). There was no difference in overall survival based on mutation (V30M vs other mutations), but survival was confounded by varied disease involvement and organs transplanted. Those who had early death (≤24 months from liver transplant) had a higher incidence of baseline peripheral neuropathy, autonomic neuropathy, lower modified BMI, and higher alkaline phosphatase. Discussion: Outcomes of orthotopic liver transplant in familial transthyretin amyloidosis are variable due to heterogeneity in mutations and patient status at the time of transplant. Familial transthyretin amyloidosis can progress, despite liver transplantation. Patients receiving combined liver, heart/kidney transplant demonstrated improved survival compared to liver transplant alone.


2000 ◽  
Vol 81 (11) ◽  
pp. 1527-1530 ◽  
Author(s):  
Masahiro Kohzuki ◽  
Takahumi Abo ◽  
Mihoko Watanabe ◽  
Yoko Goto ◽  
Nobuhiro Ohkohchi ◽  
...  

1978 ◽  
Vol 187 (3) ◽  
pp. 236-240 ◽  
Author(s):  
THOMAS E. STARZL ◽  
STUART A. SCHNECK ◽  
GIUSEPPE MAZZONI ◽  
J. ANTONIO ALDRETE ◽  
KENDRICK A. PORTER ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document